Sounds like Pfizer’s pushing further into the generic drugs business. New agreements between Pfizer and Aurobindo of India could be coming in the next month or two, Dow Jones Newswires reports this morning, citing execs from both companies who say something’s in the works. The companies already have a deal that allows Pfizer to sell dozens of generic drugs in both developed and emerging markets. Pfizer plans to set up a division to sell generic drugs in Japan , according to news reports this week. The unit will initially sell Pfizer’s own

off-patent drugs, but will also apply for licenses to sell generic versions of drugs developed by other companies, MarketWatch says. Building global generics businesses is a popular move among big companies these days, as everybody tries to figure out how to grow in the post-blockbuster era. Sanofi-Aventis recently bought several generics companies scattered around the world. GlaxoSmithKline made a deal with a South African company last year to sell off-patent drugs in the developing world. Photo: Associated Press

Read the original post:
Pfizer’s Generics Business Takes Shape